Gender-Related Differences in Pathological and Clinical Tumor Response Based on Immunohistochemical Proteins Expression in Rectal Cancer Patients Treated with Short Course of Preoperative Radiotherapy
- 1 July 2014
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 18 (7) , 1306-1318
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Investigation of possible endogenous hypoxia markers in colorectal cancerInternational Journal of Radiation Biology, 2012
- Preoperative short-course radiotherapy with delayed surgery in primary rectal cancerBritish Journal of Surgery, 2012
- Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapySurgery Today, 2011
- Gender-Related Differences in Repopulation and Early Tumor Response to Preoperative Radiotherapy in Rectal Cancer PatientsJournal of Gastrointestinal Surgery, 2011
- GLUT‐1 expression and response to chemoradiotherapy in rectal cancerInternational Journal of Cancer, 2009
- High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for predictionBritish Journal of Cancer, 2009
- Neuro-regulation of lower esophageal sphincter Predictive value of Ki67 and p53 in locally advanced rectal cancer: Correlation with thymidylate synthase and histopathological tumor regression after neoadjuvant 5-FU-based chemoradiotherapyWorld Journal of Gastroenterology, 2008
- Bromodeoxyuridine Labeling Index as an Indicator of Early Tumor Response to Preoperative Radiotherapy in Patients with Rectal CancerJournal of Gastrointestinal Surgery, 2007
- Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapyCancer, 2002
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI: Journal of the National Cancer Institute, 2000